Moreover, a positive correlation was identified between the risk score and immune checkpoints, namely CTLA4, HVEM, CD200R1, PD-1, and TIM-3, which are implicated in tumor-mediated immunosuppression and evasion, akin to the role of microglia and macrophages in glioma. Here, CD200R1 is linked to central nervous system cancer.